Rating Change
William Blair analysts initiated coverage on IDEAYA Biosciences, Inc. (NASDAQ:IDYA) with a rating of Outperform on October 16, 2026.
new coverageNASDAQ:IDYA
William Blair Initiates Coverage on IDEAYA Biosciences, Inc. (IDYA) with Outperform
William Blair analysts initiated coverage on IDEAYA Biosciences, Inc. (NASDAQ:IDYA) with a rating of Outperform on October 16, 2026.
At publication ·
What changed
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) · new coverage
- Firm
- William Blair
- Rating
- Outperform
- Price at event
- $33.03
- Market capitalization
- $2.9B
At a glance
Key takeaways
- William Blair initiated coverage of IDEAYA Biosciences with an Outperform rating on October 16, 2026.
- The stock trades at $33.03 with a $2.9B market capitalization and has gained 25.1% over the past 52 weeks.
Market Context
IDEAYA Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $33.03 with a market capitalization of $2.9B. The stock has gained 25.1% over the past 52 weeks.
Analyst coverage from William Blair provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for IDEAYA Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for IDEAYA Biosciences, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 16, 2026 | William Blair | Outperform | N/A |
| Oct 14, 2026 | Stifel | Buy | N/A |
| Sep 09, 2026 | Guggenheim | Buy | N/A |
| Sep 01, 2026 | Citizens | Market Outperform | N/A |
| Aug 05, 2026 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View IDYA Stock Page
Frequently Asked Questions
What does the Outperform rating mean for IDYA?
A rating of Outperform from William Blair reflects the analyst's outlook on IDEAYA Biosciences, Inc. (NASDAQ:IDYA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IDYA forecast page.
